When you buy through links on our articles, Future and its syndication partners may earn a commission.
Mice injected with a microRNA molecule lived longer and had fewer markers of ageing, but it’s not yet known if the treatment ...
In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...
Highlights from the first day included updates from several firms about their China businesses and M&A strategies.
ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China ImmuneOnc ...
On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and ...
Quantum-Si's NGPS technology disrupts protein analysis market, but recent equity raise and execution risks lead to Sell ...
There are certainly cheaper 3-in-1 chargers but none would grace the style section of the Sunday newspapers with the possible exception of the squatter but still lovely Belkin BoostCharge Pro 2-in ...
NVIDIA Corp. NVDA invested $1 billion across 50 startup funding rounds ... The company’s market capitalization surpassed $3 trillion in June, while its shares climbed more than 170% in 2024.
If you're looking for a portable and, more importantly, a versatile computing experience, then you should be taking a hard look at a 2-in-1 device. These devices open up a world of possibilities ...
The winter transfer portal window closed on Dec. 28. We’ve seen some heavy player movement in this free agency period. Teams are working rapidly to close these fast-paced recruitments and will get to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback